SCOPUS 정보 검색 플랫폼

Journal of Clinical Oncology

Volumn 29, Issue 15, 2011, Pages

Castration-dependent pharmacokinetics of docetaxel: Do sex and/or ABCB1 polymorphism also matter?

(3) Gligorov, Joseph a Fajac, Anne a Bernaudin, Jean François a

a SORBONNE UNIVERSITÉ (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL;

BREAST CANCER; CASTRATION; DNA POLYMORPHISM; DRUG METABOLISM; GENDER; HUMAN; LETTER; PRIORITY JOURNAL; PROSTATE CANCER; RISK BENEFIT ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT FAILURE;

CASTRATION; GONADAL STEROID HORMONES; HUMANS; MALE; P-GLYCOPROTEIN; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; TAXOIDS;

EID: 79957499290 PISSN: 0732183X EISSN: 15277755 Source Type: Journal
DOI: 10.1200/JCO.2010.34.5439 Document Type: Letter

Times cited : (2)

References (14)

1
- 2942625492
- Preclinical pharmacology of the taxanes: Implications of the differences
- Gligorov J, Lotz JP: Preclinical pharmacology of the taxanes: Implications of the differences. Oncologist 9:3-8, 2004 (suppl 2) (Pubitemid 38747838)
- (2004) Oncologist , vol.9 , Issue.SUPPL. 2 , pp. 3-8
- Gligorov, J.¹ Lotz, J.P.²

2
- 67649993396
- Future of cancer incidence in the United States: Burdens upon an aging, changing nation
- Smith BD, Smith GL, Hurria A, et al: Future of cancer incidence in the United States: Burdens upon an aging, changing nation. J Clin Oncol 27:2758-2765, 2009
- (2009) J Clin Oncol , vol.27 , pp. 2758-2765
- Smith, B.D.¹ Smith, G.L.² Hurria, A.³

3
- 78049487710
- Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancer
- Franke RM, Carducci MA, Rudek MA, et al: Castration-dependent pharmacokinetics of docetaxel in patients with prostate cancer. J Clin Oncol 28:4562-4567, 2010
- (2010) J Clin Oncol , vol.28 , pp. 4562-4567
- Franke, R.M.¹ Carducci, M.A.² Rudek, M.A.³

4
- 17444438626
- Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients
- Alexandre J, Bleuzen P, Bonneterre J, et al: Factors predicting for efficacy and safety of docetaxel in a compassionate-use cohort of 825 heavily pretreated advanced breast cancer patients. J Clin Oncol 18:562-573, 2000 (Pubitemid 30078537)
- (2000) Journal of Clinical Oncology , vol.18 , Issue.3 , pp. 562-573
- Alexandre, J.¹ Bleuzen, P.² Bonneterre, J.³ Sutherland, W.⁴ Misset, J.L.⁵ Guastalla, J.-P.⁶ Viens, P.⁷ Faivre, S.⁸ Chahine, A.⁹ Spielman, M.¹⁰ Bensmaine, A.¹¹ Marty, M.¹² Mahjoubi, M.¹³ Cvitkovic, E.¹⁴

5
- 45549101956
- Population pharmacokinetic model for docetaxel in patients with varying degrees of liver function: Incorporating cytochrome P450 3A activity measurements
- DOI 10.1038/sj.clpt.6100476, PII 6100476
- Hooker AC, Ten Tije AJ, Carducci MA, et al: Population pharmacokinetic model for docetaxel in patients with varying degrees of liver function: Incorporating cytochrome P4503A activity measurements. Clin Pharmacol Ther 84:111-118, 2008 (Pubitemid 351861492)
- (2008) Clinical Pharmacology and Therapeutics , vol.84 , Issue.1 , pp. 111-118
- Hooker, A.C.¹ Ten Tije, A.J.² Carducci, M.A.³ Weber, J.⁴ Garrett-Mayer, E.⁵ Gelderblom, H.⁶ McGuire, W.P.⁷ Verweij, J.⁸ Karlsson, M.O.⁹ Baker, S.D.¹⁰

6
- 0346057807
- Population pharmacokinetics of weekly docetaxel in patients with advanced cancer
- DOI 10.1046/j.1365-2125.2003.01956.x
- Slaviero KA, Clarke SJ, McLachlan AJ, et al: Population pharmacokinetics of weekly docetaxel in patients with advanced cancer. Br J Clin Pharmacol 57:44-53, 2004 (Pubitemid 38067949)
- (2004) British Journal of Clinical Pharmacology , vol.57 , Issue.1 , pp. 44-53
- Slaviero, K.A.¹ Clarke, S.J.² McLachlan, A.J.³ Blair, E.Y.L.⁴ Rivory, L.P.⁵

7
- 0042125511
- Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
- DOI 10.1016/S0140-6736(03)14023-8
- Chang JC, Wooten EC, Tsimelzon A, et al: Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362:362-369, 2003 (Pubitemid 36957839)
- (2003) Lancet , vol.362 , Issue.9381 , pp. 362-369
- Chang, J.C.¹ Wooten, E.C.² Tsimelzon, A.³ Hilsenbeck, S.G.⁴ Gutierrez, M.C.⁵ Elledge, R.⁶ Mohsin, S.⁷ Osborne, C.K.⁸ Chamness, G.C.⁹ Allred, D.C.¹⁰ O'Connell, P.¹¹

8
- 39749161389
- Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients
- DOI 10.1007/s10549-007-9590-z
- Chang JC, Makris A, Gutierrez MC, et al: Gene expression patterns in formalin-fixed, paraffin-embedded core biopsies predict docetaxel chemosensitivity in breast cancer patients. Breast Cancer Res Treat 108:233-240, 2008 (Pubitemid 351311356)
- (2008) Breast Cancer Research and Treatment , vol.108 , Issue.2 , pp. 233-240
- Chang, J.C.¹ Makris, A.² Gutierrez, M.C.³ Hilsenbeck, S.G.⁴ Hackett, J.R.⁵ Jeong, J.⁶ Liu, M.-L.⁷ Baker, J.⁸ Clark-Langone, K.⁹ Baehner, F.L.¹⁰ Sexton, K.¹¹ Mohsin, S.¹² Gray, T.¹³ Alvarez, L.¹⁴ Chamness, G.C.¹⁵ Osborne, C.K.¹⁶ Shak, S.¹⁷

9
- 33846504706
- A "silent" polymorphism in the MDR1 gene changes substrate specificity
- DOI 10.1126/science.1135308
- Kimchi-Sarfaty C, Oh JM, Kim IW, et al: A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315:525-528, 2007 (Pubitemid 46175758)
- (2007) Science , vol.315 , Issue.5811 , pp. 525-528
- Kimchi-Sarfaty, C.¹ Oh, J.M.² Kim, I.-W.³ Sauna, Z.E.⁴ Calcagno, A.M.⁵ Ambudkar, S.V.⁶ Gottesman, M.M.⁷

10
- 51649129871
- ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgenindependent prostate cancer treated with docetaxel
- Sissung TM, Baum CE, Deeken J, et al: ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgenindependent prostate cancer treated with docetaxel. Clin Cancer Res 14: 4543-4549, 2008
- (2008) Clin Cancer Res , vol.14 , pp. 4543-4549
- Sissung, T.M.¹ Baum, C.E.² Deeken, J.³

11
- 77955509996
- Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients
- Fajac A, Gligorov J, Rezai K, et al: Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients. Br J Cancer 103:560-566, 2010
- (2010) Br J Cancer , vol.103 , pp. 560-566
- Fajac, A.¹ Gligorov, J.² Rezai, K.³

12
- 3242695290
- P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro
- DOI 10.1023/B:PHAM.0000033017.52484.81
- Kim WY, Benet LZ: P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro. Pharm Res 21:1284-1293, 2004 (Pubitemid 38954215)
- (2004) Pharmaceutical Research , vol.21 , Issue.7 , pp. 1284-1293
- Kim, W.Y.¹ Benet, L.Z.²

13
- 1642263200
- P-Glycoprotein Increases the Efflux of the Androgen Dihydrotestosterone and Reduces Androgen Responsive Gene Activity in Prostate Tumor Cells
- DOI 10.1002/pros.10354
- Fedoruk MN, Gimé nez-Bonafé P, Guns ES, et al: P-glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cells. Prostate 59:77-90, 2004 (Pubitemid 38387845)
- (2004) Prostate , vol.59 , Issue.1 , pp. 77-90
- Fedoruk, M.N.¹ Gimenez-Bonafe, P.² Guns, E.S.³ Mayer, L.D.⁴ Nelson, C.C.⁵

14
- 77956938954
- Impact of age, sex, and comorbidity on cancer therapy and disease progression
- Pal SK, Hurria A: Impact of age, sex, and comorbidity on cancer therapy and disease progression. J Clin Oncol 28:4086-4093, 2010
- (2010) J Clin Oncol , vol.28 , pp. 4086-4093
- Pal, S.K.¹ Hurria, A.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.